The Pharmaceutical District in Mosogar,
Delta State, Nigeria, is a Public-Private-Partnershipdriven initiative,
with distinct zones for pharmaceutical companies, biotechnology
companies, medical device companies and Contract Research Organisations
(CROs). Occupying 450 hectares of land and carefully planned, a Special
Purpose Vehicle (SPV) has been set up for its management. The SPV has
obtained a financial guarantee for all its private investors from a
London Bank.
We seek to attract investors and partner with
local and international pharmaceutical companies for drug production. We
also seek to attract pharmaceutical companies to locate their branches
in the district for the manufacture of generic drugs at affordable
prices for consumers. The final goal is to encourage start-ups, and
attract existing Nigerian and international Pharma companies to the
Pharma District, Mosogar. The district has also made provisions for
manufacturers of medical devices such as syringes, needles, laboratory
supplies and other disposables such as diapers and surgical drapes. This
district will contribute to healthcare, stimulate the state’s economy
and create employment.
Estimates of the size of the
pharmaceutical market in Nigeria vary significantly. In 2009, the
Pharmaceutical Manufacturing Group of the Manufacturers’ Association of
Nigeria (PMGMAN) estimated the size of the total pharmaceuticals and
healthcare products market to be in excess of N320 billion (US$ 2
billion) annually. The estimated market for prescription ethical
pharmaceuticals is US$ 500 million and that for over the counter (OTC)
pharmaceuticals about US$ 900 million. Furthermore, PMG-MAN estimates
the Nigerian market for biological products (including vaccines,
insulin, interferon, etc.) to be worth about US$ 100 million. In
addition, related healthcare and lifestyle products account for about
US$ 500 million. The market for the entire West-African Sub-Region is at
least US$ 15 billion per annum. This district truly promises good
return on investments.
https://www.facebook.com/groups/DelPharm/
No comments:
Post a Comment